Business Description
Solasia Pharma KK
ISIN : JP3436500007
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 12.13 | |||||
Equity-to-Asset | 0.84 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.1 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 6.1 | |||||
Beneish M-Score | -5.12 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.7 | |||||
3-Year EBITDA Growth Rate | 50.3 | |||||
3-Year EPS without NRI Growth Rate | 42.7 | |||||
3-Year FCF Growth Rate | 56.1 | |||||
3-Year Book Growth Rate | -28.7 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 60.86 | |||||
9-Day RSI | 50.53 | |||||
14-Day RSI | 44.65 | |||||
6-1 Month Momentum % | -28.57 | |||||
12-1 Month Momentum % | -36.17 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.33 | |||||
Quick Ratio | 2.91 | |||||
Cash Ratio | 2.48 | |||||
Days Inventory | 111.19 | |||||
Days Sales Outstanding | 193.33 | |||||
Days Payable | 364.74 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12.4 | |||||
Shareholder Yield % | -7.16 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 54.46 | |||||
Operating Margin % | -184.6 | |||||
Net Margin % | -180.23 | |||||
FCF Margin % | -58.18 | |||||
ROE % | -50.07 | |||||
ROA % | -41.78 | |||||
ROIC % | -65.4 | |||||
ROC (Joel Greenblatt) % | -454.07 | |||||
ROCE % | -48.94 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 7.35 | |||||
PB Ratio | 2.51 | |||||
Price-to-Tangible-Book | 6.21 | |||||
EV-to-EBIT | -3.57 | |||||
EV-to-EBITDA | -6.42 | |||||
EV-to-Revenue | 6.53 | |||||
EV-to-FCF | -11.22 | |||||
Price-to-Net-Current-Asset-Value | 7.54 | |||||
Price-to-Net-Cash | 12.56 | |||||
Earnings Yield (Greenblatt) % | -28.01 | |||||
FCF Yield % | -7.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Solasia Pharma KK Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil 円) | 617 | ||
EPS (TTM) (円) | -6.63 | ||
Beta | 0.81 | ||
Volatility % | 33.91 | ||
14-Day RSI | 44.65 | ||
14-Day ATR (円) | 2.064098 | ||
20-Day SMA (円) | 26.65 | ||
12-1 Month Momentum % | -36.17 | ||
52-Week Range (円) | 23 - 71 | ||
Shares Outstanding (Mil) | 173.94 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Solasia Pharma KK Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Solasia Pharma KK Stock Events
Event | Date | Price(円) | ||
---|---|---|---|---|
No Event Data |
Solasia Pharma KK Frequently Asked Questions
What is Solasia Pharma KK(TSE:4597)'s stock price today?
When is next earnings date of Solasia Pharma KK(TSE:4597)?
Does Solasia Pharma KK(TSE:4597) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |